It is a pharma private limited company based in Noida, Uttar Pradesh, India, established in 1999.
1999 | Noida, Uttar Pradesh, India | ActiveAgnivesh Pharmaceuticals Private Limited, a active private limited company, was established on 01 October 1999 in Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239UP1999PTC119393. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹4.76 M.
It upholds a compliant status. Its leadership includes Gourav (Additional Director), Vijay Bhai (Director), Devendra Mohan Seroglou (Additional Director). Past directors included Gaurav Hasswani, Vijay Bhai, Akash Sharma. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2023. It is based at A-95, Sector-63, Noida, Uttar Pradesh, 201301.
U24239UP1999PTC119393
119393
01 October 1999
₹7.50 M
₹4.76 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Agnivesh Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gourav | Additional Director | 01 Mar 2025 | Current |
| Vijay Bhai | Director | 27 Jul 2024 | Current |
| Devendra Mohan Seroglou | Additional Director | 14 Sep 2024 | Current |
| Amit Jain | Director | 27 Jul 2024 | Current |
| Dharampal Gupta | Director | 04 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Oct 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 04 Dec 2017 | Past |
| Pramod Abcsdd | Director | 03 Sep 2017 | Past |
| Pramod Abcsdd | Director | 30 Mar 2012 | Past |
| Pramod Abcsdd | Additional Director | 08 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Agnivesh Pharmaceuticals Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 9.29% increase. The company also saw a substantial fall in profitability, with a 302.3% decrease in profit. The company's net worth dipped by a decrease of 4.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Agnivesh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Agnivesh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Agnivesh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agnivesh Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Gourav was appointed as a Additional Director was appointed as a Additional Director on 01 Mar 2025 & has been associated with this company since 9 months 2 days . was completed.
The activity Agnivesh Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was completed.
The activity Devendra Mohan Seroglou was appointed as a Additional Director was appointed as a Additional Director on 14 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Vijay Bhai was appointed as a Director was appointed as a Director on 27 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Amit Jain was appointed as a Director was appointed as a Director on 27 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
The activity Agnivesh Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur. was completed.
The CIN of Agnivesh Pharmaceuticals Private Limited is U24239UP1999PTC119393.
Agnivesh Pharmaceuticals Private Limited is headquartered at A-95, Sector-63, Noida, Uttar Pradesh, 201301.
Agnivesh Pharmaceuticals Private Limited was incorporated on 01 October 1999.
The current directors of Agnivesh Pharmaceuticals Private Limited are
The primary industry of Agnivesh Pharmaceuticals Private Limited is Pharma.
Agnivesh Pharmaceuticals Private Limited is unlisted.
The authorized capital of Agnivesh Pharmaceuticals Private Limited is ₹7.50 M, and the paid-up capital is ₹4.76 M.
The compliance status of Agnivesh Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX